Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jennison Associates LLC lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 198.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 160,972 shares of the biotechnology company’s stock after buying an additional 106,962 shares during the quarter. Jennison Associates LLC’s holdings in Bio-Techne were worth $13,341,000 at the end of the most […]
Lwmg LLC purchased a new stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 15,285 shares of the biotechnology company’s stock, valued at approximately $1,267,000. A number of other hedge funds and other […]
Bio-Techne Co. (NASDAQ:TECH – Get Rating) announced a quarterly dividend on Wednesday, May 3rd, Zacks reports. Investors of record on Monday, May 15th will be given a dividend of 0.08 per share by the biotechnology company on Friday, May 26th. This represents a $0.32 dividend on an annualized basis and a yield of 0.39%. The […]
California Public Employees Retirement System increased its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 302.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 348,072 shares of the biotechnology company’s stock after purchasing an additional 261,515 shares during the quarter. California Public Employees […]
Bio-Techne (NASDAQ:TECH – Get Rating) had its price objective increased by Robert W. Baird from $99.00 to $100.00 in a report released on Thursday, The Fly reports. Other equities research analysts have also recently issued research reports about the stock. SVB Leerink cut their price objective on shares of Bio-Techne from $125.00 to $110.00 and […]